Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing and .

Publication

Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing and .

Journal Paper/Review - Feb 15, 2024

Brune Jakob E, Dickenmann Michael, Sidler Daniel, Walti Laura N, Golshayan Délaviz, Manuel Oriol, Haidar Fadi, Neofytos Dionysios, Schnyder Aurelia, Boggian Katia, Müller Thomas F, Schachtner Thomas, Khanna Nina, Schaub Stefan, Wehmeier Caroline, Swiss Transplant Cohort Study

Citation

Brune J, Dickenmann M, Sidler D, Walti L, Golshayan D, Manuel O, Haidar F, Neofytos D, Schnyder A, Boggian K, Müller T, Schachtner T, Khanna N, Schaub S, Wehmeier C, Swiss Transplant Cohort Study. Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing and . Front Med (Lausanne) 2024; 11:1329778.

Type

Journal Paper/Review (English)

Journal

Front Med (Lausanne) 2024; 11

Publication Date

Feb 15, 2024

Issn Print

2296-858X

Pages

1329778

Brief description/objective

are often responsible for urinary tract infection (UTI) in kidney transplant recipients. Among these, or producing extended-spectrum beta-lactamase (ESBL) are emerging. However, there are only scarce data on frequency and impact of ESBL-UTI on transplant outcomes.